Meeting
2018 ASCO Annual Meeting
A validation study of stratification by the 55-gene classifier for assessing recurrence risk in stage II colon cancer: The 55 STAR study (UMIN23879).
Authors
Shigeki Yamaguchi
Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka-Shi, Japan
Shigeki Yamaguchi , Kazuo Hase , Eiji Shinto , Eiji Oki , Mototsugu Shimokawa , Megumi Ishiguro , Masaru Morita , Tetsuya Kusumoto , Naohiro Tomita , Yojiro Hashiguchi , Masafumi Tanaka , Shinobu Ohnuma , Sachiyo Tada , Tomoko Matsushima
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3526)
DOI
10.1200/JCO.2018.36.15_suppl.3526
Abstract #
3526
Poster Bd #
19
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
First Author: Greg Yothers
Poster
2018 Gastrointestinal Cancers Symposium
The 12-gene Oncotype DX Colon Recurrence Score (RS) test: Experience with > 20,000 stage 2 patients (pts).
First Author: Helen Bailey
Poster
2014 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
First Author: Jeanne Tie
Poster
2012 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
First Author: Ramon Salazar